Cargando…

Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy

BACKGROUND: Although cell surface immune checkpoint proteins (ICPs) such as PD-1 expressed on T cells are associated with T-cell exhaustion, HIV disease progression, and AIDS events, they have shown limited utility in predicting non-AIDS morbidity. Given that ICPs also exist in soluble forms and are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Premeaux, Thomas A, Moser, Carlee B, McKhann, Ashley, Hoenigl, Martin, Yeung, Stephen T, Pang, Alina P S, Corley, Michael J, Lederman, Michael M, Landay, Alan L, Gianella, Sara, Ndhlovu, Lishomwa C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826032/ https://www.ncbi.nlm.nih.gov/pubmed/35146038 http://dx.doi.org/10.1093/ofid/ofab570

Ejemplares similares

Plasma galectin-9 as a predictor of adverse non-AIDS events in persons with chronic HIV during suppressive antiretroviral therapy
por: Premeaux, Thomas A., et al.
Publicado: (2021)

Associations Between Plasma Immunomodulatory and Inflammatory Mediators With VACS Index Scores Among Older HIV-Infected Adults on Antiretroviral Therapy
por: Premeaux, Thomas A., et al.
Publicado: (2020)

Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2016)

Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

The latent HIV reservoir: current advances in genetic sequencing approaches
por: Moar, Preeti, et al.
Publicado: (2023)

Emerging Insights on Caspases in COVID-19 Pathogenesis, Sequelae, and Directed Therapies
por: Premeaux, Thomas A., et al.
Publicado: (2022)

Role of Natural Killer Cells in HIV-Associated Malignancies
por: Leal, Fabio E., et al.
Publicado: (2017)

Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection
por: Yeung, Stephen T., et al.
Publicado: (2022)

A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
por: Presti, Rachel M, et al.
Publicado: (2021)

Allergy Principles and Practice. Third Edition
por: McKhann, Guy
Publicado: (1989)

Lung Cancer Staging: A Tutorial for the Macintosh
por: McKhann, Guy
Publicado: (1990)

The Long and Winding Road: Review: Madness and Memory: The Discovery of Prions—A New Biological Principal of Disease
por: McKhann, Guy
Publicado: (2014)

Mucosal-homing natural killer cells are associated with aging in persons living with HIV
por: Kroll, Kyle W., et al.
Publicado: (2022)

Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race
por: Bhagwat, Priya, et al.
Publicado: (2018)

Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status
por: Gowda, Charitha, et al.
Publicado: (2017)

Respiratory Anatomy and Physiology
por: McKhann, Guy M.
Publicado: (1988)

Biochemistry. 3rd edition
por: McKhann, Guy M.
Publicado: (1988)

Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection
por: Norris, Philip J., et al.
Publicado: (2016)

A machine learning approach utilizing DNA methylation as an accurate classifier of COVID-19 disease severity
por: Bowler, Scott, et al.
Publicado: (2022)

Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection
por: D'Antoni, Michelle L., et al.
Publicado: (2019)

Non-AIDS-Defining Events in Human Immunodeficiency Virus Controllers Versus Antiretroviral Therapy–Controlled Patients: A Cohort Collaboration From the French National Agency for Research on AIDS CO21 (CODEX) and CO06 (PRIMO) Cohorts
por: Manto, Carmelite, et al.
Publicado: (2023)

Unanticipated Effects of New Drug Availability on Antiretroviral Durability: Implications for Comparative Effectiveness Research
por: Eaton, Ellen F., et al.
Publicado: (2016)

Recent Trends and Effectiveness of Antiretroviral Regimens Among Men Who Have Sex With Men Living With HIV in the United States: The Multicenter AIDS Cohort Study (MACS) 2008–2017
por: Li, Xiuhong, et al.
Publicado: (2019)

Antiretroviral Therapy as Prevention of … Pneumococcal Infections?
por: Lesourd, Anaïs, et al.
Publicado: (2016)

Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection
por: El Kamari, Vanessa, et al.
Publicado: (2021)

Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research
por: Premeaux, Thomas A., et al.
Publicado: (2021)

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
por: Rhee, Soo-Yon, et al.
Publicado: (2020)

Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment
por: Shikuma, Cecilia M., et al.
Publicado: (2023)

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
por: El Moussaoui, Majdouline, et al.
Publicado: (2020)

Characterization of Circulating Fibrocytes in People Living with HIV on Stable Antiretroviral Therapy
por: Dean, Logan S., et al.
Publicado: (2022)

ANTIGENIC SPECIFICITIES ON MURINE SARCOMA CELLS : RECIPROCAL RELATIONSHIP BETWEEN NORMAL TRANSPLANTATION ANTIGENS (H-2) AND TUMOR-SPECIFIC IMMUNOGENICITY
por: Haywood, Gerald R., et al.
Publicado: (1971)

Association of First-Line and Second-Line Antiretroviral Therapy Adherence
por: Ramadhani, Habib O., et al.
Publicado: (2014)

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial
por: Baker, Jason V., et al.
Publicado: (2016)

Longitudinal Study of DNA Methylation and Epigenetic Clocks Prior to and Following Test-Confirmed COVID-19 and mRNA Vaccination
por: Pang, Alina P. S., et al.
Publicado: (2022)

Association of Cytomegalovirus DNA and Immunologic Markers of Cardiovascular Disease
por: Garg, Ankita, et al.
Publicado: (2019)

Weighing the Odds: Novel β-Lactam/β-Lactamase Inhibitor Use in Hospital-Acquired and Ventilator-Associated Pseudomonas aeruginosa Pneumonia for Patients Who Are Morbidly Obese
por: Kunz Coyne, Ashlan J, et al.
Publicado: (2023)

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options
por: Meloni, Seema T, et al.
Publicado: (2017)

Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling
por: Colomb, Florent, et al.
Publicado: (2019)

Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States
por: Hoenigl, Martin, et al.
Publicado: (2022)

Control and Elimination of Schistosomiasis as a Public Health Problem: Thresholds Fail to Differentiate Schistosomiasis Morbidity Prevalence in Children
por: Wiegand, Ryan E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7035gsdmvp2n48u2413ja8g03e